FASLG and neoplasm: In summary, although the “classical” tumor evasion associated with the loss of CD95 expression by tumor cells exposed to CD95L-expressing immune cells remains valid, this oncogenic process might be counterbalanced by the induction of an NF-κB-driven pro-inflammatory response observed in tumor cells losing CD95.